Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery	Hepato Cellular Carcinoma	Not yet recruiting	Phase 4	2026-07-29		NCT07734766

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Second Affiliated Hospital of Xi'an Jiaotong University	33

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials